Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
Rene C. Adam(Western Sydney University), Viktoria Gusarova(Regeneron (United States)), Sara Hamon, Cristopher V. Van Hout(Regeneron (United States)), Helen H. Hobbs(Southwestern Medical Center), Ivory J. Mintah(Regeneron (United States)), Joseph S. Lee(Regeneron (United States)), Jonathan C. Cohen(Southwestern Medical Center), Corey A. Alexa-Braun(Regeneron (United States)), Lisa M. Shihanian(Regeneron (United States)), Poulabi Banerjee(Cardiovascular Institute of the South), George D. Yancopoulos(Regeneron (United States)), Hye In Kim(Regeneron (United States)), Andrew Murphy(DePaul University), Mark W. Sleeman(Regeneron (United States)), Jesper Gromada(Rapt Therapeutics (United States))
Cited by 202
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k